Search Page

1

Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma.

Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Olaciregui NG, Tabatabai G, Carcaboso AM, Aboagye EO, Suwan K, Hajitou A. Przystal JM, et al. Among authors: Hajitou A. EMBO Mol Med. 2019 Apr;11(4):e8492. doi: 10.15252/emmm.201708492. EMBO Mol Med. 2019. PMID: 30808679 Free PMC article.

Cite

Share

2

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.

Przystal JM, Hajji N, Khozoie C, Renziehausen A, Zeng Q, Abaitua F, Hajitou A, Suwan K, Want E, Bomalaski J, Szlosarek P, O'Neill K, Crook T, Syed N. Przystal JM, et al. Among authors: Hajitou A. Cell Death Dis. 2018 Dec 13;9(12):1192. doi: 10.1038/s41419-018-1195-4. Cell Death Dis. 2018. PMID: 30546006 Free PMC article.

Cite

Share

3

CRISPR/Cas9: Transcending the Reality of Genome Editing.

Chira S, Gulei D, Hajitou A, Zimta AA, Cordelier P, Berindan-Neagoe I. Chira S, et al. Among authors: Hajitou A. Mol Ther Nucleic Acids. 2017 Jun 16;7:211-222. doi: 10.1016/j.omtn.2017.04.001. Epub 2017 Apr 8. Mol Ther Nucleic Acids. 2017. PMID: 28624197 Free PMC article. Review.

Cite

Share

4

Bacteriophage-derived vectors for targeted cancer gene therapy.

Pranjol MZ, Hajitou A. Pranjol MZ, et al. Among authors: Hajitou A. Viruses. 2015 Jan 19;7(1):268-84. doi: 10.3390/v7010268. Viruses. 2015. PMID: 25606974 Free PMC article. Review.

Cite

Share

5

Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.

Chira S, Gulei D, Hajitou A, Berindan-Neagoe I. Chira S, et al. Among authors: Hajitou A. Trends Biotechnol. 2018 Jul;36(7):653-660. doi: 10.1016/j.tibtech.2018.01.014. Epub 2018 Feb 22. Trends Biotechnol. 2018. PMID: 29478674 Free article.

Cite

Share

6

Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract.

Namdee K, Khongkow M, Boonrungsiman S, Nittayasut N, Asavarut P, Temisak S, Saengkrit N, Puttipipatkhachorn S, Hajitou A, Ruxrungtham K, Yata T. Namdee K, et al. Among authors: Hajitou A. Mol Ther Nucleic Acids. 2018 Sep 7;12:33-44. doi: 10.1016/j.omtn.2018.04.012. Epub 2018 May 1. Mol Ther Nucleic Acids. 2018. PMID: 30195771 Free PMC article.

Cite

Share

7

Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma.

Asavarut P, O'Neill K, Syed N, Hajitou A. Asavarut P, et al. Among authors: Hajitou A. Ther Deliv. 2014;5(9):975-90. doi: 10.4155/tde.14.58. Ther Deliv. 2014. PMID: 25375341 Review.

Cite

Share

8

Selective Inhibition of Histone Deacetylation in Melanoma Increases Targeted Gene Delivery by a Bacteriophage Viral Vector.

Campbell S, Suwan K, Waramit S, Aboagye EO, Hajitou A. Campbell S, et al. Among authors: Hajitou A. Cancers (Basel). 2018 Apr 21;10(4):125. doi: 10.3390/cancers10040125. Cancers (Basel). 2018. PMID: 29690504 Free PMC article.

Cite

Share

9

Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.

Dobroff AS, D'Angelo S, Eckhardt BL, Ferrara F, Staquicini DI, Cardó-Vila M, Staquicini FI, Nunes DN, Kim K, Driessen WHP, Hajitou A, Lomo LC, Barry M, Krishnamurthy S, Sahin A, Woodward WA, Prossnitz ER, Anderson RL, Dias-Neto E, Brown-Glaberman UA, Royce ME, Ueno NT, Cristofanilli M, Hortobagyi GN, Marchiò S, Gelovani JG, Sidman RL, Arap W, Pasqualini R. Dobroff AS, et al. Among authors: Hajitou A. Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12780-12785. doi: 10.1073/pnas.1615288113. Epub 2016 Oct 24. Proc Natl Acad Sci U S A. 2016. PMID: 27791177 Free PMC article.

Cite

Share

10

Bacteriophage Mediates Efficient Gene Transfer in Combination with Conventional Transfection Reagents.

Donnelly A, Yata T, Bentayebi K, Suwan K, Hajitou A. Donnelly A, et al. Among authors: Hajitou A. Viruses. 2015 Dec 8;7(12):6476-89. doi: 10.3390/v7122951. Viruses. 2015. PMID: 26670247 Free PMC article.

Cite

Share